伊沃西地尼作为二线或三线治疗晚期IDH1突变胆管癌的药物

{"title":"伊沃西地尼作为二线或三线治疗晚期IDH1突变胆管癌的药物","authors":"NVMO-commissie BOM","doi":"10.24078/onco.1970.1.23981","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"84 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ivosidenib als tweede- of derdelijnsbehandeling bij het gevorderd IDH1-gemuteerd cholangiocarcinoom\",\"authors\":\"NVMO-commissie BOM\",\"doi\":\"10.24078/onco.1970.1.23981\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":221680,\"journal\":{\"name\":\"Medische Oncologie\",\"volume\":\"84 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medische Oncologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24078/onco.1970.1.23981\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medische Oncologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24078/onco.1970.1.23981","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}